Facial Hair Reduction Using Intense Pulsed Light (IPL) & Alexandrite Laser
Launched by NHS GREATER GLASGOW AND CLYDE · Oct 26, 2011
Trial Information
Current as of April 26, 2025
Unknown status
Keywords
ClinConnect Summary
This is a randomised (splitface)controlled trial, comparing the use of the Intense Pulsed Light (IPL) system 650 advance handpiece against the Alexandrite Laser for the purposes of female facial hair reduction. Previous studies have shown that the alexandrite laser is superior to IPL in achieving hair reduction. A new handpiece (Lynton, Lumina 650 advance) available for the IPL system is designed to further optimise its use in removing female facial hair (particularly those hair colours previously unresponsive to treatment). This study will compare the alexandrite laser to the IPL system us...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female Patients
- • Minimum age 16years old
- • Fitzpatrick skin types I-III
- • Significant facial hair.
- Exclusion Criteria:
- • Fitzpatrick skin types IV-VI
- • Age less than 16years old
- • Males
- • No visible facial hair growth
- • Use of electrolysis or depilatory creams 6weeks prior to treatment
- • Active acnes
- • Current coldsore
- • Previous facial hair removal with laser or IPL in past 12 months
- • Sun tanned skin
About Nhs Greater Glasgow And Clyde
NHS Greater Glasgow and Clyde (NHS GG&C) is one of the largest health organizations in the UK, dedicated to delivering high-quality healthcare services to a diverse population. As a clinical trial sponsor, NHS GG&C plays a pivotal role in advancing medical research and improving patient outcomes through innovative clinical studies. The organization is committed to upholding rigorous ethical standards and regulatory compliance, ensuring that all trials are conducted with the utmost care for participant safety and scientific integrity. With a focus on collaboration, NHS GG&C partners with academic institutions, healthcare professionals, and industry stakeholders to foster an environment conducive to groundbreaking research and the development of new therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Glasgow, , United Kingdom
Patients applied
Trial Officials
Adam Gilmour, MBChB, MRCS (Ed)
Principal Investigator
NHS Greater Glasgow & Clyde
Iain Mackay, MBChb, MRCS, FRCS (plast)
Study Chair
NHS Greater Glasgow & Clyde
Vivek Sivarajan, MBChB, MRCS, MD, FRCS (Plas)
Study Director
NHS Greater Glasgow & Clyde
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials